GlassScriptPhysician profile
Sarah Tariq
NPI 1821440876
$3,075.13
in general payments reported to CMS, 2019-2025
12 companies · $440 in 2025
The $440 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,160 · 2023: $684 · 2024: $791 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,915.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $729.90 | 2022-2025 | Freestyle Libre 3, Afinion 2 |
| Dexcom, INC. | $564.23 | 2022-2024 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $479.43 | 2022-2025 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $243.33 | 2024-2025 | Jardiance |
| Corcept Therapeutics | $221.50 | 2023-2024 | Korlym |
| Medtronic, INC. | $188.46 | 2022-2024 | Minimed 780g |
| Insulet Corporation | $157.52 | 2022 | |
| Beta Bionics, INC. | $138.79 | 2024 | Ilet Bionic Pancreas |
| Xeris Pharmaceuticals, INC. | $118.40 | 2022 | |
| Tandem Diabetes Care, INC. | $82.24 | 2022-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Ascendis Pharma Endocrinology INC | $81.06 | 2025 | Yorvipath |
| Lilly USA, LLC | $70.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Tariq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.